 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. News CDC Panel Mulls Cancer Vaccine UseJune 27, 2006 On Thursday, CDC's Advisory Committee on Immunization Practices is expected to recommend who should receive a recently approved cervical cancer vaccine and by what age the vaccine should be administered. Merck & Co.'s Gardasil was found to be safe and effective in protecting against two strains of the STD human papillomavirus (HPV) that are responsible for about 70 percent of cervical cancers. To be most effective, Gardasil should be given before women start having sexual intercourse, through which HPV is transmitted. Ultimately, individual states will decide who receives Gardasil and when, though they look to the CDC panel for guidance. Newsday (New York) 06.27.06; Kathleen Kerr  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
